Current landscape of pharmacovigilance in Pakistan

  • Zairah Zulfiqar Tehsil Headquarter Hospital (THQ), Murree, Pakistan
Keywords: ADR reporting, DRAP, medication safety, patient safety, pharmacovigilance

Abstract

Drug Regularity Authority of Pakistan came into being in 2012 after multiple casualties were reported due to dispensation of counterfeit & adulterated drugs. The primary purpose was to address any quality & efficacy issues related to medicines and encourage healthcare professionals to play their role in provision of safe medication therapy by practicing pharmacovigilance. Currently, a Medicine Surveillance portal for reporting is available for ADR reporting along with ADR and Drug & Device complaint forms. A new mobile app, MedSafety was recently launched to encourage public to report.

Downloads

Download data is not yet available.

References

Fornasier G, Francescon S, Leone R, Baldo P. An historical overview over Pharmacovigilance. Int J Clin Pharm. 2018 Aug;40(4):744–7.

DOI: https://doi.org/10.1007/s11096-018-0657-1

Vilhelmsson A. Consumer narratives in ADR reporting: an important aspect of public health? Experiences from reports to a Swedish consumer organization. Frontiers in Public Health.2015;3:211.

DOI: https://doi.org/10.3389/fpubh.2015.00211

Hussain R, Hassali MA. Current status and future prospects of pharmacovigilance in Pakistan. Journal of Pharmaceutical Policy and Practice. 2019 May 21;12(1):14.

DOI: https://doi.org/10.1186/s40545-019-0178-x

Uppsala Monitoring Centre. Members of the WHO Programme for International Drug Monitoring. 14 Dec 2021.

Provincial Drug Control Unit Punjab. 14 Dec 2021.

Published
2021-12-28
How to Cite
1.
Zulfiqar Z. Current landscape of pharmacovigilance in Pakistan. JSTMU [Internet]. 28Dec.2021 [cited 15May2024];4(2):75-6. Available from: https://j.stmu.edu.pk/ojs/index.php/jstmu/article/view/175